“If UK chooses U.S.-style pharmaceutical rules, it is clearly not aligning with the European model.”
“This will make regulatory cooperation much harder.”
“You cannot build a single market relationship on US standards.”
“If UK chooses U.S.-style pharmaceutical rules, it is clearly not aligning with the European model.”
“This will make regulatory cooperation much harder.”
“You cannot build a single market relationship on US standards.”